Novel Regenerative Approaches for Osteoarthritis

A multinational biopharmaceutical company with long-standing presence in rheumatology and more recently, immuno-dermatology and bone disorders, are interested in the musculoskeletal area by exploring further indications in this space.

Osteoarthritis (OA) is a disease of high prevalence with high unmet need due to severe pain and joint impairment. It is a multifactorial and heterogenous disease where pathology is only partially understood. Current treatments focus on the pain aspect of the disease with no approved disease modifying therapies that promote ...